$ONCE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Spark Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Spark Therapeutics, Inc.. Get notifications about new insider transactions in Spark Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 37.18 | 12,000 | 446,160 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 37.18 | 12,000 | 446,160 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 0.00 | 20,325 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 0.00 | 20,325 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 3.45 | 19,951 | 68,831 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 3.45 | 19,951 | 68,831 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 68.45 | 28,389 | 1,943,227 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 68.45 | 28,389 | 1,943,227 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 40.44 | 30,000 | 1,213,200 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 40.44 | 30,000 | 1,213,200 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 56.17 | 19,500 | 1,095,315 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 56.17 | 19,500 | 1,095,315 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 50.55 | 28,000 | 1,415,400 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 50.55 | 28,000 | 1,415,400 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Sell | U | 114.50 | 4,134 | 473,343 | 0 | 4.1 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Dalton Lisa | CHIEF HUMAN RESOURC ... | Sell | U | 114.50 | 4,134 | 473,343 | 0 | 4.1 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 0.00 | 19,500 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 0.00 | 19,500 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 3.45 | 106,015 | 365,752 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 3.45 | 106,015 | 365,752 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 68.45 | 60,000 | 4,107,000 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 68.45 | 60,000 | 4,107,000 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 40.44 | 55,000 | 2,224,200 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 40.44 | 55,000 | 2,224,200 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 56.17 | 25,000 | 1,404,250 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 56.17 | 25,000 | 1,404,250 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 50.55 | 28,000 | 1,415,400 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 50.55 | 28,000 | 1,415,400 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Sell | U | 114.50 | 6,102 | 698,679 | 0 | 6.1 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Webster Stephen W | CHIEF FINANCIAL OFF ... | Sell | U | 114.50 | 6,102 | 698,679 | 0 | 6.1 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 25,786 | 88,962 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 3.45 | 17,203 | 59,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | U | 114.50 | 14,214 | 1,627,503 | 0 | 14.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Sell | U | 114.50 | 14,214 | 1,627,503 | 0 | 14.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | D | 0.00 | 2,000 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | D | 0.00 | 2,000 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | D | 55.76 | 8,000 | 446,080 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | D | 55.76 | 8,000 | 446,080 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Sell | U | 114.50 | 2,500 | 286,250 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Sell | U | 114.50 | 2,500 | 286,250 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 3.45 | 37,203 | 128,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 3.45 | 37,203 | 128,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 481,270 | 55,105,415 | 0 | 481.3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 481,270 | 55,105,415 | 0 | 481.3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 40,203 | 4,603,244 | 0 | 40.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Sell | U | 114.50 | 40,203 | 4,603,244 | 0 | 40.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 0.00 | 32,750 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 0.00 | 32,750 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 59.74 | 50,000 | 2,987,000 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 59.74 | 50,000 | 2,987,000 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 50.55 | 18,000 | 909,900 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 50.55 | 18,000 | 909,900 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Sell | U | 114.50 | 12,615 | 1,444,418 | 0 | 12.6 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | CHIEF SCIENTIFIC OF ... | Sell | U | 114.50 | 12,615 | 1,444,418 | 0 | 12.6 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 0.00 | 49,250 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 0.00 | 49,250 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.45 | 126,131 | 435,152 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.45 | 126,131 | 435,152 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 68.45 | 125,000 | 8,556,250 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 68.45 | 125,000 | 8,556,250 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 40.44 | 135,000 | 5,459,400 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 40.44 | 135,000 | 5,459,400 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 56.17 | 70,000 | 3,931,900 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 56.17 | 70,000 | 3,931,900 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 50.55 | 52,500 | 2,653,875 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 50.55 | 52,500 | 2,653,875 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 42.73 | 98,000 | 4,187,540 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 42.73 | 98,000 | 4,187,540 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Sell | U | 114.50 | 355,215 | 40,672,118 | 0 | 355.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Marrazzo Jeffrey D | CHIEF EXECUTIVE OFF ... | Sell | U | 114.50 | 355,215 | 40,672,118 | 0 | 355.2 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | High Katherine A | See Remarks | Option Exercise | D | 0.00 | 21,250 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | High Katherine A | See Remarks | Option Exercise | D | 40.44 | 13,750 | 556,050 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | High Katherine A | See Remarks | Option Exercise | D | 56.17 | 15,750 | 884,678 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | High Katherine A | See Remarks | Option Exercise | D | 50.55 | 23,625 | 1,194,244 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | High Katherine A | See Remarks | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | High Katherine A | See Remarks | Sell | U | 114.50 | 278,834 | 31,926,493 | 0 | 278.8 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 0.00 | 21,500 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 37.62 | 50,000 | 1,881,000 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 56.17 | 14,000 | 786,380 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 50.55 | 26,250 | 1,326,938 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | U | 114.50 | 38,828 | 4,445,806 | 0 | 38.8 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 3.45 | 37,203 | 128,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Altschuler Steven | Director | Option Exercise | D | 3.45 | 37,203 | 128,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Altschuler Steven | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Altschuler Steven | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Altschuler Steven | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Altschuler Steven | Director | Sell | U | 114.50 | 28,000 | 3,206,000 | 0 | 28 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | La Barge Joseph | CHIEF LEGAL OFFICER | Option Exercise | D | 0.00 | 19,500 | 0 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | La Barge Joseph | CHIEF LEGAL OFFICER | Option Exercise | D | 40.44 | 11,250 | 454,950 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | La Barge Joseph | CHIEF LEGAL OFFICER | Option Exercise | D | 56.17 | 12,500 | 702,125 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | La Barge Joseph | CHIEF LEGAL OFFICER | Option Exercise | D | 50.55 | 21,000 | 1,061,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | La Barge Joseph | CHIEF LEGAL OFFICER | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | La Barge Joseph | CHIEF LEGAL OFFICER | Sell | U | 114.50 | 200 | 22,900 | 0 | 200 to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | La Barge Joseph | CHIEF LEGAL OFFICER | Sell | U | 114.50 | 50,193 | 5,747,099 | 0 | 50.2 K to 0 (-100.00 %) |
Jun 27 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | Chief Scientific Of ... | Option Exercise | M | 0.00 | 8,375 | 0 | 16,750 | |
Jun 27 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | Chief Scientific Of ... | Payment of Exercise | F | 102.31 | 2,775 | 283,910 | 12,615 | 15.4 K to 12.6 K (-18.03 %) |
Jun 27 2019 | ONCE | Spark Therapeutics ... | Mingozzi Federico | Chief Scientific Of ... | Buy | M | 0.00 | 8,375 | 0 | 15,390 | 7 K to 15.4 K (+119.39 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Mehra Anand | Director | Buy | M | 0.00 | 1,500 | 0 | 40,203 | 38.7 K to 40.2 K (+3.88 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Buy | M | 0.00 | 1,500 | 0 | 3,000 | 1.5 K to 3 K (+100.00 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | SIGAL ELLIOT | Director | Buy | M | 0.00 | 1,500 | 0 | 14,214 | 12.7 K to 14.2 K (+11.80 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | PEREZ ROBERT J | Director | Buy | M | 0.00 | 1,500 | 0 | 2,500 | 1,000 to 2.5 K (+150.00 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 1,500 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | MILANO VINCENT | Director | Buy | M | 0.00 | 1,500 | 0 | 3,000 | 1.5 K to 3 K (+100.00 %) |